These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1411 related items for PubMed ID: 21093588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A.
    J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079
    [Abstract] [Full Text] [Related]

  • 5. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U, Czubayko F, Aigner A.
    J Control Release; 2006 May 15; 112(2):257-70. PubMed ID: 16574264
    [Abstract] [Full Text] [Related]

  • 6. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S, Prinz R, Malek A, Urban-Klein B, Sitterberg J, Bakowsky U, Czubayko F, Aigner A.
    Eur J Pharm Biopharm; 2008 Sep 15; 70(1):29-41. PubMed ID: 18499413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A.
    J Gene Med; 2010 Mar 15; 12(3):287-300. PubMed ID: 20052738
    [Abstract] [Full Text] [Related]

  • 9. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S, Aigner A.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013 Mar 15; 5(5):484-501. PubMed ID: 23720168
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
    Merkel OM, Beyerle A, Librizzi D, Pfestroff A, Behr TM, Sproat B, Barth PJ, Kissel T.
    Mol Pharm; 2009 Mar 15; 6(4):1246-60. PubMed ID: 19606864
    [Abstract] [Full Text] [Related]

  • 15. Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes.
    Höbel S, Loos A, Appelhans D, Schwarz S, Seidel J, Voit B, Aigner A.
    J Control Release; 2011 Jan 20; 149(2):146-58. PubMed ID: 20946922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A, Hamdy S, Samuel J, El-Kadi AO, Lavasanifar A, Uludağ H.
    Biomaterials; 2010 Feb 20; 31(6):1420-8. PubMed ID: 19913908
    [Abstract] [Full Text] [Related]

  • 18. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK, Lellouche E, Zigdon S, Bechor M, Michaeli S, Lellouche JP.
    Bioconjug Chem; 2013 Dec 18; 24(12):2076-87. PubMed ID: 24180511
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K, Lee MY, Kim KS, Hahn SK.
    Biomaterials; 2010 Jul 18; 31(19):5258-65. PubMed ID: 20378167
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 71.